Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook
The biologics contract development and manufacturing organization (cdmo) market in Middle East & Africa is expected to reach a projected revenue of US$ 3,547.6 million by 2033. A compound annual growth rate of 4.3% is expected of Middle East & Africa biologics contract development and manufacturing organization (cdmo) market from 2026 to 2033.
Revenue, 2025 (US$M)
$2,510.8
Estimate, 2026 (US$M)
$2,644.3
Forecast, 2033 (US$M)
$3,547.6
CAGR, 2026 - 2033
4.3%
Global Market
Related Markets
MEA biologics contract development and manufacturing organization (cdmo) market highlights
- The MEA biologics contract development and manufacturing organization (cdmo) market generated a revenue of USD 2,510.8 million in 2025.
- The market is expected to grow at a CAGR of 4.3% from 2026 to 2033.
- In terms of segment, monoclonal antibodies (mabs) was the largest revenue generating product in 2025.
- Nucleic Acid Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
| Market revenue in 2025 | USD 2,510.8 million |
| Market revenue in 2033 | USD 3,547.6 million |
| Growth rate | 4.3% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies (mabs) |
| Fastest growing segment | Nucleic Acid Therapeutics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies (mAbs), Recombinant Proteins & Enzymes, Vaccines, Cell & Gene Therapies, Nucleic Acid Therapeutics, Other Product |
| Key market players worldwide | Lonza, Catalent Pharma Solutions, Samsung BioLogics, WuXi Biologics., Thermo Fisher Scientific Inc, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim, Rentschler Biopharma SE, AGC Biologics, Charles River Laboratories International Inc., Siegfried Holding AG, Sandoz, GenScript, Vetter Pharma, IDT Biologika |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.2% of the global biologics contract development and manufacturing organization (cdmo) market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,786.2 million by 2033.
No credit card required*
Publish Date: Apr 24, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biologics Contract Development And Manufacturing Organization (CDMO) Market Scope
Biologics Contract Development And Manufacturing Organization (CDMO) Market segmentation & scope
Biologics Contract Development And Manufacturing Organization (CDMO) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Siegfried Holding AG | View profile | 4,180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | www.siegfried.ch |
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | www.rentschler-biopharma.com |
| AGC Biologics | View profile | 1001-5000 | Bothell, Washington, United States, North America | www.agcbio.com/ |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | www.samsungbiologics.com/ |
| IDT Biologika | View profile | 1001-5000 | Dessau, Sachsen-Anhalt, Germany, Europe | idt-biologika.de/ |
| Catalent Pharma Solutions | View profile | 5001-10000 | Somerset, New Jersey, United States, North America | www.catalent.com |
| Charles River Laboratories International Inc. | View profile | - | - | - |
| GenScript | View profile | - | - | - |
Middle East & Africa Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies (Mabs) was the largest segment with a revenue share of 43.79% in 2025.
Horizon Databook has segmented the Middle East & Africa biologics contract development and manufacturing organization (cdmo) market based on monoclonal antibodies (mabs), recombinant proteins & enzymes, vaccines, cell & gene therapies, nucleic acid therapeutics, other product covering the revenue growth of each sub-segment from 2021 to 2033.
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Product Outlook (Revenue, USD Million , 2021-2033)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic Acid Therapeutics
- Other Product
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Service Outlook (Revenue, USD Million , 2021-2033)
- Packaging and Labelling
- Regulatory Affairs
- Logistics & Storage
- Other Service
- Contract Development
- Contract Manufacturing
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Source Outlook (Revenue, USD Million , 2021-2033)
- Mammalian
- Microbial
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Commerical
- Clinical
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market Therapeutic Area Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Neurological Diseases
- Other Therapeutic Area
- Middle East & Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Other End Use
Reasons to subscribe to Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook databook
- Our clientele includes a mix of Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa Biologics Contract Development And Manufacturing Organization (Cdmo) Market, 2021-2033 (US$M)
MEA biologics contract development and manufacturing organization (cdmo) market statistics, by product, 2021-2033 (US$M)
